新闻Borealis Ventures partners with Merck.“Borealis Ventures is excited to collaborate with Merck, a leader in immuno-oncology, and leverage their expertise in the pursuit of therapies to treat patients who have progressed on previous anti-PD-1 therapy.
新闻Borealis Ventures invests into Ovation.io, Inc $21.5M.Ovation.io has raised the $21.5m in Series B funding in a round led by SignalFire, with contributions by Madrona Venture Group, Borealis Ventures, StageDotO Ventures and industry veteran David Shaw.
